首頁
瀏覽量: 244
- 產品名稱： Research Grade Catumaxomab ( 卡妥索單抗 )
- 產品貨號： CSD00133
- 貨期： 現貨
- 價格與訂購： 2480
- 數量：
庫存： 100
- 規(guī)格： 100μg
- 產品信息
- 如何訂購
貨號（Catalog No.）
CSD00133
通用名INN
Catumaxomab
純度(Purity)
>95%
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內毒素(Endotoxin level)
Please contact with the lab for this information.
產品描述(Description)
Catumaxumab is a trifunctional monoclonal antibody developed for use in cancer treatment. It has affinity for T-cells, accessory immune cells, and cancer cells. Catumaxumab was initially authorized for market by the European Medicines Agency in April 2009 for the treatment of malignant ascites 3. Its market authorization was withdrawn in the EU in June 2017 at the manufacturer's request due to the company's insolvency. Catumaxumab was approved for market in Canada in May 2012 for the same condition Label. It is currently available under the brand name Removab.
別名(Alternative names)
Musmus G2a kappa,anti-EPCAM (Ho-3/TP-A-01)/Rat sp.G2b lambda,anti-CD3E (26/II/6-1.2),TPBs01
靶點;物種(Specificity target name;species)
CD3E/EpCAM[Homo sapiens]
種類(Species)
Mus musculus,Rattus sp,Hybrid
受體鑒定(Receptor identification)
IgG2a-kappa/G2b-lambda
分子量(MV)
150511.00 Da
CAS
509077-98-9
存儲條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .
地 址：
產品銷售：
E - mail ：
郵 編：
Amily
